AI assistant
Dare Bioscience, Inc. — Director's Dealing 2017
Jul 21, 2017
34825_dirs_2017-07-21_66f83ffd-4b7e-45c4-a656-7b17ff56448e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2017-07-19
Reporting Person: RASTETTER WILLIAM H (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-07-19 | Option to Purchase Common Stock | $6.56 | A | 2000 | Acquired | 2027-07-19 | Common Stock (2000) | Direct |
Footnotes
F1: The exercise price reported reflects the 10 for 1 reverse stock split effected by the Corporation on July 20, 2017.
F2: Dr. Rastetter was awarded options to purchase shares of the Corporation's common stock in connection with his service as a member of the Board of Directors (the "Director Options") pursuant to the Corporation's 2014 Stock Incentive Plan.
F3: The Director Options will vest in equal annual installments over a three-year period measured from the date of grant, subject to Dr. Rastetter's continued service to the Corporation and will become exercisable in full upon a change of control of the Corporation.